L705-2475 Screening compound: 3-METHYL-7-[3-OXO-3-(4-PHENYL-1,2,3,6-TETRAHYDROPYRIDIN-1-YL)PROPANESULFONYL]-2,3,4,5-TETRAHYDRO-1,5-BENZOTHIAZEPIN-4-ONE

L705-2475 Screening compound: 3-METHYL-7-[3-OXO-3-(4-PHENYL-1,2,3,6-TETRAHYDROPYRIDIN-1-YL)PROPANESULFONYL]-2,3,4,5-TETRAHYDRO-1,5-BENZOTHIAZEPIN-4-ONE
L705-2475 Screening compound: 3-METHYL-7-[3-OXO-3-(4-PHENYL-1,2,3,6-TETRAHYDROPYRIDIN-1-YL)PROPANESULFONYL]-2,3,4,5-TETRAHYDRO-1,5-BENZOTHIAZEPIN-4-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound L705-2475
3-METHYL-7-[3-OXO-3-(4-PHENYL-1,2,3,6-TETRAHYDROPYRIDIN-1-YL)PROPANESULFONYL]-2,3,4,5-TETRAHYDRO-1,5-BENZOTHIAZEPIN-4-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L705-2475

Molecular Formula

C24H26N2O4S2 (C24 H26 N2 O4 S2)

Compound Name

3-METHYL-7-[3-OXO-3-(4-PHENYL-1,2,3,6-TETRAHYDROPYRIDIN-1-YL)PROPANESULFONYL]-2,3,4,5-TETRAHYDRO-1,5-BENZOTHIAZEPIN-4-ONE

IUPAC name

3-methyl-7-[3-oxo-3-(4-phenyl-1236-tetrahydropyridin-1-yl)propanesulfonyl]-2345-tetrahydro-15-benzothiazepin-4-one

SMILES

CC(CSc(ccc(S(CCC(N(CC1)CC=C1c1ccccc1)=O)(=O)=O)c1)c1N1)C1=O

InChI

InChI=1S/C24H26N2O4S2/c1-17-16-31-22-8-7-20(15-21(22)25-24(17)28)32(29,30)14-11-23(27)26-12-9-19(10-13-26)18-5-3-2-4-6-18/h2-9,15,17H,10-14,16H2,1H3,(H,25,28)/t17-/m1/s1

InChI Key

SNUCLTPBGOXDSP-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD27471850

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.61

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.190

Distribution Coefficient, logD

3.189

Water Solubility, LogSw

-3.61

Polar Surface Area

70.333

Acid Dissociation Constant (pKa)

10.74

Base Dissociation Constant (pKb)

-4.20

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

L705-2475 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L705-2475 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L705-2475?
Check Price and Availability of L705-2475, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L705-2475 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L705-2475
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L705-2475
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L705-2475 available by request